These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 29353875)

  • 1. Cost-effectiveness analyses of genetic and genomic diagnostic tests.
    Payne K; Gavan SP; Wright SJ; Thompson AJ
    Nat Rev Genet; 2018 Apr; 19(4):235-246. PubMed ID: 29353875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardized decision support in next generation sequencing reports of somatic cancer variants.
    Dienstmann R; Dong F; Borger D; Dias-Santagata D; Ellisen LW; Le LP; Iafrate AJ
    Mol Oncol; 2014 Jul; 8(5):859-73. PubMed ID: 24768039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions.
    Payne K; Eden M; Davison N; Bakker E
    Per Med; 2017 May; 14(3):235-247. PubMed ID: 29767583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic screening: birthright or earned with age?
    Mollison L; Berg JS
    Expert Rev Mol Diagn; 2017 Aug; 17(8):735-738. PubMed ID: 28641021
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinically Responsive Genomic Analysis Pipelines: Elements to Improve Detection Rate and Efficiency.
    Sundercombe SL; Berbic M; Evans CA; Cliffe C; Elakis G; Temple SEL; Selvanathan A; Ewans L; Quayum N; Nixon CY; Dias KR; Lang S; Richards A; Goh S; Wilson M; Mowat D; Sachdev R; Sandaradura S; Walsh M; Farrar MA; Walsh R; Fletcher J; Kirk EP; Teunisse GM; Schofield D; Buckley MF; Zhu Y; Roscioli T
    J Mol Diagn; 2021 Jul; 23(7):894-905. PubMed ID: 33962052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial and nuclear disease panel (Mito-aND-Panel): Combined sequencing of mitochondrial and nuclear DNA by a cost-effective and sensitive NGS-based method.
    Abicht A; Scharf F; Kleinle S; Schön U; Holinski-Feder E; Horvath R; Benet-Pagès A; Diebold I
    Mol Genet Genomic Med; 2018 Nov; 6(6):1188-1198. PubMed ID: 30406974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.
    Bennette CS; Gallego CJ; Burke W; Jarvik GP; Veenstra DL
    Genet Med; 2015 Jul; 17(7):587-95. PubMed ID: 25394171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the Value of Next-Generation Sequencing Tests in a Dynamic Environment.
    Burris HA; Saltz LB; Yu PP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():139-146. PubMed ID: 30231307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using "Big Data" in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions.
    Wordsworth S; Doble B; Payne K; Buchanan J; Marshall DA; McCabe C; Regier DA
    Value Health; 2018 Sep; 21(9):1048-1053. PubMed ID: 30224108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-Based Materials as Multiplex Quality Controls and Calibrators for Clinical Next-Generation Sequencing Assays.
    Sims DJ; Harrington RD; Polley EC; Forbes TD; Mehaffey MG; McGregor PM; Camalier CE; Harper KN; Bouk CH; Das B; Conley BA; Doroshow JH; Williams PM; Lih CJ
    J Mol Diagn; 2016 May; 18(3):336-349. PubMed ID: 27105923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Systematic Review of Value Criteria for Next-Generation Sequencing/Comprehensive Genomic Profiling to Inform Value Framework Development.
    Augustovski F; Colaci C; Mills M; Chavez D; Argento F; Alfie V; Pichon Riviere A; Kanavos P; Alcaraz A
    Value Health; 2024 May; 27(5):670-685. PubMed ID: 38403113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using Cost-Effectiveness Analysis to Quantify the Value of Genomic-Based Diagnostic Tests: Recommendations for Practice and Research.
    Spackman E; Hinde S; Bojke L; Payne K; Sculpher M
    Genet Test Mol Biomarkers; 2017 Dec; 21(12):705-716. PubMed ID: 29027820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A scoping study to explore the cost-effectiveness of next-generation sequencing compared with traditional genetic testing for the diagnosis of learning disabilities in children.
    Beale S; Sanderson D; Sanniti A; Dundar Y; Boland A
    Health Technol Assess; 2015 Jun; 19(46):1-90. PubMed ID: 26132578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies.
    Banerjee S
    Surg Oncol Clin N Am; 2024 Apr; 33(2):231-242. PubMed ID: 38401907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility of the traditional medical genetics diagnostic evaluation in the context of next-generation sequencing for undiagnosed genetic disorders.
    Shashi V; McConkie-Rosell A; Rosell B; Schoch K; Vellore K; McDonald M; Jiang YH; Xie P; Need A; Goldstein DB
    Genet Med; 2014 Feb; 16(2):176-82. PubMed ID: 23928913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis comparing companion diagnostic tests for EGFR, ALK, and ROS1 versus next-generation sequencing (NGS) in advanced adenocarcinoma lung cancer patients.
    Schluckebier L; Caetano R; Garay OU; Montenegro GT; Custodio M; Aran V; Gil Ferreira C
    BMC Cancer; 2020 Sep; 20(1):875. PubMed ID: 32928143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solving the molecular diagnostic testing conundrum for Mendelian disorders in the era of next-generation sequencing: single-gene, gene panel, or exome/genome sequencing.
    Xue Y; Ankala A; Wilcox WR; Hegde MR
    Genet Med; 2015 Jun; 17(6):444-51. PubMed ID: 25232854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultra-Rapid Reporting of GENomic Targets (URGENTseq): Clinical Next-Generation Sequencing Results within 48 Hours of Sample Collection.
    Patel KP; Ruiz-Cordero R; Chen W; Routbort MJ; Floyd K; Rodriguez S; Galbincea J; Barkoh BA; Hatfield D; Khogeer H; Kanagal-Shamanna R; Yin CC; Zuo Z; Loghavi S; Ok CY; DiNardo CD; Luthra R; Medeiros LJ
    J Mol Diagn; 2019 Jan; 21(1):89-98. PubMed ID: 30577887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving health care through personal genomics.
    Rehm HL
    Nat Rev Genet; 2017 Apr; 18(4):259-267. PubMed ID: 28138143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Cost-effectiveness of Genetic Screening for Familial Hypercholesterolemia: a Systematic Review.
    Rosso A; Pitini E; D'Andrea E; Massimi A; De Vito C; Marzuillo C; Villari P
    Ann Ig; 2017; 29(5):464-480. PubMed ID: 28715059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.